Related Articles
Anti-angiogenesis target therapy for advanced osteosarcoma (Review)
Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer
S100A4 interacts with mutant p53 and affects gastric cancer MKN1 cell autophagy and differentiation
CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition
Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma